Cost Containment Strategies for Healthcare Plans

July 6, 2021
Shelby Skrhak

The rising costs of prescription medications in the U.S. are top of mind for anyone who relies on daily doses for their health. Between 2000 and 2017, some studies put the prescription drug cost increases in the U.S. as high as 76%. So, what are consumers to do?

Greg Santulli, CEO of RX Valet, offered an alternative for those looking to lower their overall prescription medication costs, and he spoke with host Shelby Skrhak about RX Valet’s solution.

“RX Valet was founded five years ago, really on the principle of bringing better value to consumers and members of RX Valet,” Santulli said. “RX Valet is offered primarily through memberships through various vehicles either as a benefit as part of your health plan or as some other type of health offering.”

The fundamental tenant of RX Valet is to give access to medications at a reasonable price.

Santulli recognized and affirmed that drug prices had reached an untenable situation in the U.S. If someone doesn’t have the correct type of healthcare coverage, many of the medications one sees advertised on television are unobtainable.

“Or they were unobtainable until you go to our site and be part of the RX Valet family,” Santulli said. “What we do is we find ways to get you the medications that you need at reasonable prices.”

RX Valet provides the engine that searches for those savings and gives customers options to gain people access to lower-cost medications. If receiving prescriptions by mail is an option for someone, the savings can add up, but RX Valet provides savings at a participant’s pharmacy, too. Santulli said RX Valet would connect the dots to get people the medications they need, generic or brand-name, at an affordable price, in the method that works best for them.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Recent Episodes

advancing health equity
View episode

During the 2024 HIMSS Conference, an annual highlight for digital health innovators, Dr. Bryan O. Buckley, the Health Equity Director at NCQA, shared transformative insights on advancing health equity in digital healthcare. This interview, conducted by Healthcare Rethink host Brian Urban, delves into the strategies that can reshape healthcare delivery through technology and equity….

Validation
View episode

Validation and qualification are some of the most critical phases in the lifecycle of equipment and processes within industries like pharmaceuticals and manufacturing. Driven by the necessity to adhere to stringent regulatory standards and ensure high operational efficiency, the distinction between ‘qualification of equipment’ and ‘validation of processes’ becomes paramount. As the landscape of…

health equity is earned and learned
View episode

In today’s rapidly evolving healthcare landscape, “health equity is earned and learned” captures a vital truth. This critical concept underscores the need for a proactive and educated approach to bridge healthcare outcomes and access disparities. On the Healthcare Rethink podcast, host Brian Urban welcomes Bonzo Reddick, MD, MPH, FAAFP, a prominent Public Health Leader…